Dendritic
Cell (DC) therapy represents a new and promising
immunotherapeutic approach for treatment
of advanced cancer as well as for
prevention of cancer. As Dr. Harmon Eyre,
the VP of Research at the AMA commented: “Patients' responses
are far out of proportion to anything that
any current therapy could do”. For decades,
cancer researchers have been interested
in immunologic treatments
against cancer but with little progress.
However, recent advances lead
to successful implementation of Dendritic Cell therapy
with reports of complete responses even
in stage IV cancer patients who have failed
all other therapies. Dendritic Cell (DC) Therapy or so-called Dendritic Cell vaccine is a newly emerging and potent form of immune therapy used to treat cancer. To learn more about vaccine and Dendritic Cell therapy for cancer, please read the following: